drugset / Trial / NCT01254565
Safety, Tolerability and Efficacy of Etelcalcetide in Hemodialysis Patients With Secondary Hyperparathyroidism
RandomizedSequentialDouble-blindTreatment
Summary
The purpose of this study is to characterize the safety and tolerability and efficacy of multiple ascending doses of etelcalcetide in hemodialysis patients for the treatment of secondary hyperparathyroidism (HPT).
Timeline
- Start
- 2011-02-20
- Primary completion
- 2011-07
- Completion
- 2011-08-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Etelcalcetide | Other / unclassified | 5 mg | Intravenous |
| Subject | Etelcalcetide | Other / unclassified | 10 mg | Intravenous |
| Subject | Etelcalcetide | Other / unclassified | 20 mg | Intravenous |